SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?


To: Anthony@Pacific who wrote (51758)2/15/2000 2:35:00 PM
From: McNabb Brothers  Read Replies (1) | Respond to of 122087
 
Bought RMBS this morning sold this afternoon! Oh almost forgot on Private site!!!!!!!!!!!!

Tony you are funny!

Hank



To: Anthony@Pacific who wrote (51758)2/15/2000 2:35:00 PM
From: Michael T Currie  Respond to of 122087
 
ABTE - held short since low 9s. Interesting statement in their earnings release today. Sounds like a pretty desperate situation to me. I doubled my short at 5 1/4 this morning.

-------------------------

The Company also reports their auditors have completed their audit and expect to
issue their report by the end of the week. Their report will include disclosure
of uncertainties regarding the Company's ability to continue as a going concern.
The Company incurred significant operating losses during the fiscal year ended
October 31, 1999. Significant payments were also made, both during and
subsequent to October 31, 1999, to redeem the Series B Preferred Stock and to
reduce obligations for loss contracts assumed in 1998 in the acquisition of
MFSNT. The Company has borrowed the maximum available under its existing Senior
Credit Facility and is in default of the related covenants. The lender has the
right to demand payment and the Company has insufficient liquidity to pay such
amounts, if called. The Company has not yet been successful in obtaining
alternative financing and my have insufficient liquidity to fund its continuing
operations. Consequently, there is substantial doubt about the Company's ability
to continue as a going concern.
Management's plans in regard to these matters are as follows:
1. As described above, Dial and AIS were closed during fiscal year 1999.
Together, Dial and AIS used cash flows from operations of approximately
$7.7 million and $5.1 million during the fiscal years ended October 31,
1999 and 1998.

2. Subsequent to October 31, 1999, approximately $25.5 million of the
Company's indebtedness was converted to Common Stock of the Company.

3. Subsequent to October 31, 1999, approximately $6.0 million of the
Company's Series B Preferred Stock was converted to Common Stock of the
Company. Concurrent with such conversion, the Company's remaining
Series B Preferred Stock was redeemed for approximately $10.0 million
that was funded through the issuance of $15.0 million of Series C
Preferred Stock.

4. The Company is working to obtain a new credit facility with an
unrelated financial institution and is pursuing additional financing
through discussions with various independent investors.



To: Anthony@Pacific who wrote (51758)2/15/2000 3:55:00 PM
From: BC  Respond to of 122087
 
lucked out bought more AVAN while it was on sale today at 7 9/16



To: Anthony@Pacific who wrote (51758)2/15/2000 5:41:00 PM
From: ztect  Read Replies (2) | Respond to of 122087
 
ot: TOP TEN SIGNS YOU'VE JOINED A CHEAP HMO

10. Annual breast exam conducted at Hooters.

9. Directions to your doctor's office include,
"take a left when you enter the trailer park,"

8. Tongue depressors taste faintly of Fudgesicles.

7. The only proctologist in the plan is "Gus"
from Roto-Rooter.

6. Only item listed under Preventive Care coverage
is "an apple a day"

5. Your "primary care physician" is wearing the pants
you gave to Goodwill last month.

4. "Patient responsible for 200% of out-of-network charges"
is not a typo.

3. The only expense covered 100% is embalming.

2. With your last HMO, your Prozac didn't come in
different colors with little "m"s on them.

...AND THE #1 SIGN YOU JOINED A CHEAP HMO...

1. You asked for Viagra and you get a popsicle stick
and duct tape.



To: Anthony@Pacific who wrote (51758)2/16/2000 10:38:00 AM
From: Tassi  Read Replies (1) | Respond to of 122087
 
MCAR...undiscovered B2B stock @ $2.. added today.. This could be
a big one if the RxSheets.com B2B plan get executed..
very low risk..

MEDCARE TECHNOLOGIES ANNOUNCES RXSHEETS.COM BEGINS MARKETING EFFORTS TO STRENGTHEN LEADERSHIP POSITION IN ONLINE PHARMACEUTICAL SAMPLING
--------------------------------------------------------------------------------
OAK BROOK, Ill.--(BUSINESS WIRE)--Feb. 10, 2000--RxSheets.com, a
wholly owned subsidiary of MedCare Technologies, Inc. (NASDAQ: MCAR.O)
announced today that it is increasing its marketing efforts to
continue the growth of its leading online business. The Company plans
on introducing its innovative business-to-business web site, featuring
online pharmaceutical sampling, to physicians across the country.
"Based on the initial strong response from physicians and
technical development of our site, we feel it is the appropriate
strategic time to commence the first phase of our marketing plan,"
said Jeff Aronin, President and Chief Executive Officer. "We expect
the excellent demand for RxSheets.com to continue and such growth to
improve and strengthen our competitive position."
RxSheets.com (www.rxsheets.com) is an innovative and leading
business-to-business web site catering to the pharmaceutical needs of
the practicing physician. The pharmaceutical focused site was launched
in October 1999 with a strategy to revolutionize the process by which
physicians obtain pharmaceutical samples and drug related information.
Many pharmaceutical companies offer physicians samples of their drugs
as part of their marketing promotions to physicians. A trial sample of
a drug is often the most effective way to get a doctor to use a
pharmaceutical company's product.
The Company performed a sample marketing effort in November 1999
to physicians and received an overwhelming response. As a result of
its initial marketing and ongoing networking efforts, over 10,000
physicians have registered with RxSheets.com.
"Since our launch, we have received a healthy volume of sample
requests from physicians and are facilitating the delivery of the
samples," said Aronin. "RxSheets.com is an excellent example on how
the Internet can improve the efficiencies and productivity of the
physician's practice."
RxSheets.com offers the following information and services: Drug
Samples Request OAK BROOK, Ill.--(BUSINESS WIRE)--Feb. 10, 2000--RxSheets.com, a
wholly owned subsidiary of MedCare Technologies, Inc. (NASDAQ: MCAR.O)
announced today that it is increasing its marketing efforts to
continue the growth of its leading online business. The Company plans
on introducing its innovative business-to-business web site, featuring
online pharmaceutical sampling, to physicians across the country.
"Based on the initial strong response from physicians and
technical development of our site, we feel it is the appropriate
strategic time to commence the first phase of our marketing plan,"
said Jeff Aronin, President and Chief Executive Officer. "We expect
the excellent demand for RxSheets.com to continue and such growth to
improve and strengthen our competitive position."
RxSheets.com (www.rxsheets.com) is an innovative and leading
business-to-business web site catering to the pharmaceutical needs of
the practicing physician. The pharmaceutical focused site was launched
in October 1999 with a strategy to revolutionize the process by which
physicians obtain pharmaceutical samples and drug related information.
Many pharmaceutical companies offer physicians samples of their drugs
as part of their marketing promotions to physicians. A trial sample of
a drug is often the most effective way to get a doctor to use a
pharmaceutical company's product.
The Company performed a sample marketing effort in November 1999
to physicians and received an overwhelming response. As a result of
its initial marketing and ongoing networking efforts, over 10,000
physicians have registered with RxSheets.com.
"Since our launch, we have received a healthy volume of sample
requests from physicians and are facilitating the delivery of the
samples," said Aronin. "RxSheets.com is an excellent example on how
the Internet can improve the efficiencies and productivity of the
physician's practice."
RxSheets.com offers the following information and services: Drug
Samples Request Center, FDA Approvals Library, Clinical Studies
Center, News Center, Investment Center provided by Morgan Stanley Dean
Witter Online, HealthCare Calendar and Pharmaceutical Newsletter.
MedCare Technologies, Inc. is a healthcare technology service
company that focuses on under-served high growth markets. The
Company's RxSheets.com (www.rxsheets.com), offers a wide array of
compelling and focused information and services, including drug sample
requests for physicians, drug protocols and studies, research
information, and other pertinent aspects of the pharmaceutical market.
The Company began by developing the MedCare Program, now the nations
leading conservative therapy for treating urinary incontinence, a
hidden health condition that, at approximately $26 billion, costs more
than diabetes and bypass surgery combined.
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance and
underlying assumptions and other statements which are other than
statements of historical facts. These statements are subject to
uncertainties and risks including, but not limited to, product and
service demand and acceptance, changes in technology, changes in
insurance reimbursement, economic conditions, the impact of
competition and pricing, government regulation, and other risks
defined in this document and in statements filed from time to time
with the Securities and Exchange Commission. All such forward-looking
statements, whether written or oral, and whether made by or on behalf
of the Company are expressly qualified by these cautionary statements
and any other cautionary statements which may accompany the
forward-looking statements. In addition, the Company disclaims any
obligation to update any forward-looking statements to reflect events
or circumstances after the date hereof.

--30--ajg Center, FDA Approvals Library, Clinical Studies
Center, News Center, Investment Center provided by Morgan Stanley Dean
Witter Online, HealthCare Calendar and Pharmaceutical Newsletter.
MedCare Technologies, Inc. is a healthcare technology service
company that focuses on under-served high growth markets. The
Company's RxSheets.com (www.rxsheets.com), offers a wide array of
compelling and focused information and services, including drug sample
requests for physicians, drug protocols and studies, research
information, and other pertinent aspects of the pharmaceutical market.
The Company began by developing the MedCare Program, now the nations
leading conservative therapy for treating urinary incontinence, a
hidden health condition that, at approximately $26 billion, costs more
than diabetes and bypass surgery combined.
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance and
underlying assumptions and other statements which are other than
statements of historical facts. These statements are subject to
uncertainties and risks including, but not limited to, product and
service demand and acceptance, changes in technology, changes in
insurance reimbursement, economic conditions, the impact of
competition and pricing, government regulation, and other risks
defined in this document and in statements filed from time to time
with the Securities and Exchange Commission. All such forward-looking
statements, whether written or oral, and whether made by or on behalf
of the Company are expressly qualified by these cautionary statements
and any other cautionary statements which may accompany the
forward-looking statements. In addition, the Company disclaims any
obligation to update any forward-looking statements to reflect events
or circumstances after the date hereof.

--30--ajg/in*

CONTACT: MedCare Technologies, Inc.
Bruce Byots, 630/ 472-5306
Web Site: www.medcareonline.com

KEYWORD: ILLINOIS
INDUSTRY KEYWORD: PHARMACEUTICAL

Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com

Copyright 2000, Business Wire